EW FY 2023 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

FY 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.0B-6.9% YoY

Gross Profit

$4.0B79.3% margin

Operating Income

$1.4B28.5% margin

Net Income

$1.4B28.0% margin

EPS (Diluted)

$2.30

Cash Flow

Operating Cash Flow

$896M

Free Cash Flow

$630M

Stock-Based Comp.

$139M

Balance Sheet

Total Assets

$9.4B

Total Liabilities

$2.6B

Stockholders' Equity

$6.7B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.0B	$5.4B	-6.9%
Gross Profit	$4.0B	$4.2B	-5.8%
Operating Income	$1.4B	$1.7B	-16.2%
Net Income	$1.4B	$1.5B	-7.9%